Updated
Updated · The Globe and Mail · Jul 23
StockStory Picks 3 Healthcare Stocks as Sector Gains 10% in 6 Months
Updated
Updated · The Globe and Mail · Jul 23

StockStory Picks 3 Healthcare Stocks as Sector Gains 10% in 6 Months

1 articles · Updated · The Globe and Mail · Jul 23

Summary

  • StockStory named Vertex Pharmaceuticals, Alignment Healthcare and Zoetis as healthcare stocks with competitive advantages and potential to beat the market.
  • 10% sector gains over the past six months nearly matched the S&P 500, but the report said regulation remains a key risk for healthcare investors.
  • Vertex, valued at $119.9 billion, was highlighted for 13.8% annual revenue growth over five years, strong free cash flow and high returns on capital.
  • Alignment was cited for 45.4% annual revenue growth over two years, 28.5% annual EPS growth over four years and an 11-point free-cash-flow margin expansion.
  • Zoetis rounded out the list on steady constant-currency growth, strong cash generation and efficient capital deployment, extending the report's focus from drugmakers to animal health and Medicare Advantage.

Insights

Can Zoetis's booming livestock business truly offset the unexpected slump in post-pandemic pet healthcare spending?
How will Vertex's groundbreaking gene therapy expansion for toddlers reshape its market dominance beyond cystic fibrosis?
Will AI-driven claims automation be the secret weapon that finally pushes Medicare Advantage plans into sustained profitability?